New Zealand markets closed

Matinas BioPharma Holdings, Inc. (MTNB)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.1749-0.0084 (-4.58%)
At close: 04:00PM EDT
0.1759 +0.00 (+0.57%)
After hours: 07:44PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 43.87M
Enterprise value 33.67M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)34.67
Price/book (mrq)2.28
Enterprise value/revenue 30.72
Enterprise value/EBITDA -1.48

Trading information

Stock price history

Beta (5Y monthly) 1.55
52-week change 3-71.76%
S&P500 52-week change 322.38%
52-week high 30.8900
52-week low 30.1100
50-day moving average 30.2409
200-day moving average 30.2263

Share statistics

Avg vol (3-month) 31.62M
Avg vol (10-day) 3951.36k
Shares outstanding 5250.82M
Implied shares outstanding 6262.86M
Float 8211.96M
% held by insiders 12.53%
% held by institutions 110.43%
Shares short (15 Apr 2024) 43.19M
Short ratio (15 Apr 2024) 41.07
Short % of float (15 Apr 2024) 41.31%
Short % of shares outstanding (15 Apr 2024) 41.27%
Shares short (prior month 15 Mar 2024) 41.32M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,168.43%

Management effectiveness

Return on assets (ttm)-42.49%
Return on equity (ttm)-82.11%

Income statement

Revenue (ttm)1.1M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA -23.37M
Net income avi to common (ttm)-22.94M
Diluted EPS (ttm)-0.1100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.76M
Total cash per share (mrq)0.06
Total debt (mrq)3.56M
Total debt/equity (mrq)18.48%
Current ratio (mrq)5.93
Book value per share (mrq)0.09

Cash flow statement

Operating cash flow (ttm)-15.28M
Levered free cash flow (ttm)-6.85M